-
Mashup Score: 3ESOU 2022: Follow-Up of Stage I and II Seminoma: What’s New? - 2 year(s) ago
ESOU 2022 follow-up of early stage seminoma, personalized management of testis cancer, Trial of Imaging and Surveillance in Seminoma Testis (TRISST), WATChmAN trial.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1ESOU 2022: Management of Indeterminate Testicular Masses - 2 year(s) ago
ESOU 2022 early detection and personalized management of testis cancer, management of indeterminate testicular masses, Indeterminate lesions do not require immediate orchidectomy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Management of indeterminate #Testicular masses. Presentation by @Dr_Andrology @UCLDivofSurgery. #ESOU22 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/Bxv6rsxxvG @Uroweb @ucl https://t.co/sYBiREusDM
-
-
Mashup Score: 3#esou22 - 19th Meeting of the EAU Section of Oncological Urology (ESOU22) - Social Media Analytics and Transcripts - 2 year(s) ago
ESOU22 will be a fusion of round-table discussions, scientific lectures, and rapid-fire presentations delivered with an interactive approach regardless of
Source: SymplurCategories: Latest Headlines, UrologyTweet-
Good to see #uroSoMe and #medtwitter is showing signs of recovery at #esou22 Top Influencers of #esou22 👉 @Uroweb @MRoupret @JGomezRivas @UrowebESU @MariaJRibal @dr_coops @joniau https://t.co/x02RlpCbCc przez @symplur
-
-
Mashup Score: 1ESOU 2022: Stage II Seminoma: What Is the Role for Retroperitoneal Lymph Node Dissection? - 2 year(s) ago
2022 EAU Section of Oncological Urology (ESOU), management of testis cancer, role of retroperitoneal lymph node dissection (RPLND) in stage II seminoma, SEMS trial evaluated surgery in metastatic seminoma.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Stage II #seminoma: What is the role for retroperitoneal lymph node dissection? Presentation by @siadaneshmand @KeckMedUSC. #ESOU22 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/E8djkiu2cj @Uroweb @theNCI @USC @USC_Urology https://t.co/gmZZ6rbc0H
-
-
Mashup Score: 0ESOU 2022: An Update on Thromboprophylaxis During Chemotherapy for Metastatic Germ Cell Tumours - 2 year(s) ago
ESOU 2022 the incidence of venous thromboembolism in patients undergoing first-line chemotherapy for metastatic germ cell tumors.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
An update on thromboprophylaxis during chemotherapy for metastatic #GermCell tumors. Presentation by @CDFankhauser. #ESOU22 written coverage by @WallisCJD @UofT on UroToday > https://t.co/1znq8FaCrK @Uroweb https://t.co/B7fKh7vOvv
-
-
Mashup Score: 6ESOU 2022: En Bloc Resection in Non-muscle Invasive Bladder Cancer: Where Do We Stand? - 2 year(s) ago
ESOU 2022 utilization of en bloc resection in non-muscle invasive bladder cancer (NMIBC), En bloc resection of bladder tumors, clinical trial comparing TURBT and en-bloc resection of bladder tumor.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
En bloc resection in non-muscle invasive #BladderCancer #NMIBC: Where do we stand? Presentation by @AlbertoBreda1 @FPuigvert. #ESOU22 written coverage by @zklaassen_md @GACancerCenter. #ReadNow on UroToday > https://t.co/sjfY3VO0Yr @Uroweb https://t.co/jTPwY6gSOk
-
-
Mashup Score: 1ESOU 2022: 3D Augmented Reality in Robotic Assisted Partial Nephrectomy – What’s Next? - 2 year(s) ago
ESOU 2022 role of augmented reality in robotic assisted partial nephrectomy, superimposition of 3-dimensional (3D) virtual models over the real anatomy of patients, robotic assisted partial nephrectomy.
Source: www.urotoday.comCategories: Latest Headlines, UrologyTweet-
3D augmented reality in robotic assisted partial nephrectomy – What’s next? Presentation by @PorpigliaF @unito. #ESOU22 written coverage by @WallisCJD @UofT. #ReadNow on UroToday > https://t.co/OcFqqovTow @Uroweb https://t.co/R4n5WIMvFe
-
-
Mashup Score: 8ESOU 2022: Early Cystectomy: Selection of the Best Candidate and Outcomes. BRAVO Trial Implications for Patient Selection - 2 year(s) ago
ESOU 2022 results of the BRAVO trial, early cystectomy for patients with high-risk non-muscle invasive bladder cancer, Renal Cancer, radical cystectomy in high-risk non-muscle invasive bladder cancer.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Early cystectomy: selection of the best candidate and outcomes. #BRAVO trial implications for patient selection. Presented by @amassonlecomte @HopSaintLouis. #ESOU22 written coverage by @WallisCJD @UofT > https://t.co/IMJ6MbRD7H @Uroweb https://t.co/EHkZykwV6c
-
-
Mashup Score: 1ESOU 2022: New Tools for the Conservative Management of Upper Tract Urothelial Carcinoma - 2 year(s) ago
ESOU 2022 patients with upper tract urothelial carcinoma (UTUC), radical nephroureterectomy is preferred for patients with high-grade disease, UTUC ablation with thulium:YAG.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
New tools for the conservative management of upper tract #UrothelialCarcinoma #UTUC. Presented by @GuidoGiusti. #ESOU22 written coverage by @WallisCJD @UofT on UroToday > https://t.co/QV8ShjFZNo @Uroweb https://t.co/nXLyje40b3
-
-
Mashup Score: 8
2022 EAU Section of Oncological Urology (ESOU) Annual Meeting, Artificial Intelligence for Kidney Cancer Diagnosis, outcomes to human generated R.E.N.A.L. scores.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
#PrecisionMedicine – #ArtificialIntelligence for #KidneyCancer diagnosis. Presentation by @foxal72. #ESOU22 written coverage by @WallisCJD @UofT on UroToday > https://t.co/NZAo9MktdJ @Uroweb https://t.co/SSmA4Wovfk
-
Follow-up of stage I and II #seminoma: What’s new? Presentation by @robert_huddart @ICR_London. #ESOU22 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/FHzJBp1gWo @royalmarsdenNHS @Uroweb https://t.co/Hs8rjrh5f6